These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Long-term drug therapy of rheumatoid arthritis and remission]. Piaĭ L; Piaĭ S Ter Arkh; 2000; 72(5):21-5. PubMed ID: 11109613 [TBL] [Abstract][Full Text] [Related]
3. Remission in rheumatoid arthritis: wishful thinking or clinical reality? Sesin CA; Bingham CO Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659 [TBL] [Abstract][Full Text] [Related]
4. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis. Wolfe F; Rasker JJ; Boers M; Wells GA; Michaud K Arthritis Rheum; 2007 Aug; 57(6):935-42. PubMed ID: 17665487 [TBL] [Abstract][Full Text] [Related]
5. [Remission in rheumatoid arthritis (apropos the article by L. T. Piaĭ and S. V. Vikhliaeva The remission of rheumatoid arthritis--myth or reality?--Revmatologiia, 1990, No. 2, pp. 68-72)]. Murav'ev IuV Revmatologiia (Mosk); 1991; (3):46-7. PubMed ID: 1812565 [No Abstract] [Full Text] [Related]
6. [Drug-induced remission in the severe progressive variant of rheumatoid arthritis]. Krel' AA; Semenova OIu; Kanevskaia MZ; Shekhter AB Ter Arkh; 1994; 66(1):24-9. PubMed ID: 8146788 [TBL] [Abstract][Full Text] [Related]
7. Predictors of remission, normalized physical function, and changes in the working situation during follow-up of patients with early rheumatoid arthritis: an observational study. Verschueren P; Esselens G; Westhovens R Scand J Rheumatol; 2009; 38(3):166-72. PubMed ID: 19169906 [TBL] [Abstract][Full Text] [Related]
8. Early rheumatoid arthritis: strategies for prevention and management. Combe B Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):27-42. PubMed ID: 17350542 [TBL] [Abstract][Full Text] [Related]
9. Most people over age 50 in the general population do not meet ACR remission criteria or OMERACT minimal disease activity criteria for rheumatoid arthritis. Sokka T; Mäkinen H; Hannonen P; Pincus T Rheumatology (Oxford); 2007 Jun; 46(6):1020-3. PubMed ID: 17405761 [TBL] [Abstract][Full Text] [Related]
10. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Hakala M; Järvinen P; Ahonen J; Forsberg S; Leirisalo-Repo M; Arthritis Rheum; 2005 Jan; 52(1):36-41. PubMed ID: 15641055 [TBL] [Abstract][Full Text] [Related]
11. What is the natural history of rheumatoid arthritis? Ollier WE; Harrison B; Symmons D Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):27-48. PubMed ID: 11358413 [TBL] [Abstract][Full Text] [Related]
12. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872 [TBL] [Abstract][Full Text] [Related]
13. Innovative treatment strategies for patients with rheumatoid arthritis. van der Kooij SM; Allaart CF; Dijkmans BA; Breedveld FC Curr Opin Rheumatol; 2008 May; 20(3):287-94. PubMed ID: 18388520 [TBL] [Abstract][Full Text] [Related]
14. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial. Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010 [TBL] [Abstract][Full Text] [Related]
16. A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up. Verstappen SM; van Albada-Kuipers GA; Bijlsma JW; Blaauw AA; Schenk Y; Haanen HC; Jacobs JW; Ann Rheum Dis; 2005 Jan; 64(1):38-43. PubMed ID: 15130899 [TBL] [Abstract][Full Text] [Related]
17. Auranofin: first choice for remission-inducing drug (RID) therapy in rheumatoid arthritis? Bandilla K; Missler B; Klein-Reesink B Scand J Rheumatol Suppl; 1986; 63():47-54. PubMed ID: 3474777 [TBL] [Abstract][Full Text] [Related]
19. [Approximation to the cost of pharmacological treatment of rheumatoid arthritis in Spain]. Mera Varela A; Blanco Rodríguez J; Caamaño Freire M An Med Interna; 2003 Mar; 20(3):114-21. PubMed ID: 12756895 [TBL] [Abstract][Full Text] [Related]
20. What is the natural history of rheumatoid arthritis? Pincus T; Callahan LF Rheum Dis Clin North Am; 1993 Feb; 19(1):123-51. PubMed ID: 8356248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]